GANX Competitors & Alternatives
Compare Gain Therapeutics Inc with similar stocks in the same industry
Biotechnology
GANX
Main Stock$1.71
Tradestie Score
55
Market Cap
$65.43M
Revenue Growth
-1.0%
Analyst Upside
+324.0%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.94
|
$133.50M | - | 52 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.73
|
$114.01M | - | 44 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$24.80
|
$110.20M | - | 61 | Compare |
|
COYA
Coya Therapeutics, Inc. Common Stock
|
$4.81
|
$97.84M | - | 47 | Compare |
|
HOWL
Werewolf Therapeutics, Inc. Common Stock
|
$0.93
|
$89.17M | - | 54 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$2.86
|
$84.52M | - | 59 | Compare |
|
CNTB
Connect Biopharma Holdings Limited Ordinary Shares
|
$0.93
|
$83.60M | - | 53 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$9.68
|
$67.94M | - | 45 | Compare |
|
INAB
IN8bio, Inc. Common Stock
|
$1.40
|
$10.26M | - | 33 | Compare |
|
FNCHQ
FNCHQ
|
- | - | - | - | Compare |
More GANX Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry